![Pascal Brenneisen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pascal Brenneisen
Chief Executive Officer at TOPADUR Pharma AG
Profile
Pascal Brenneisen was the founder of Bottmedical AG, a company founded in 2019, where he held the title of Director.
He is currently the Chief Executive Officer at Topadur Pharma AG since 2015, Independent Director at Stratpharma AG since 2017, and Director at Bottneuro AG.
Mr. Brenneisen's former position includes being the Chairman at Sandoz Pharmaceuticals AG.
Pascal Brenneisen active positions
Companies | Position | Start |
---|---|---|
Stratpharma AG
![]() Stratpharma AG Pharmaceuticals: MajorHealth Technology Stratpharma AG specializes in the development and licensing of novel medical devices and pharmaceutical products. Its products are used for scar management, abnormal scar prevention and invasive therapies. The company was founded in 2005 and is headquartered in Basel, Switzerland.^ | Director/Board Member | 2017-08-20 |
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | Chief Executive Officer | 2023-03-31 |
Bottneuro AG
![]() Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | Director/Board Member | - |
Former positions of Pascal Brenneisen
Companies | Position | End |
---|---|---|
Bottmedical AG
![]() Bottmedical AG Medical SpecialtiesHealth Technology Bottmedical AG is a Swiss company that produces CINNA & Naturaligner, which are the world's first antibacterial braces. The private company is based in Basel, Switzerland. These braces correct, protect, and retain teeth while continuously supporting oral hygiene. The company was founded in 2019 by Pascal Brenneisen, Tino Töpper, Jeannette von Jackowski, Bert Müller, Bekim Osmani, Guido Sigron, Tobias Hollritt. Tino Töpper has been the CEO since 2019. | Founder | - |
Sandoz Pharmaceuticals AG
![]() Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Chairman | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 5 |
---|---|
Sandoz Pharmaceuticals AG
![]() Sandoz Pharmaceuticals AG BiotechnologyHealth Technology Sandoz Pharmaceuticals AG develops and produces biopharmaceuticals. The firm specializes in the production of biopharmaceutical and biosimilars for the treatment and prevention of chronic diseases. It focuses on finding cure for diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, and inherited metabolic disorders. The company was founded on January 6, 2006 and is headquartered in Rotkreuz, Switzerland. | Health Technology |
Stratpharma AG
![]() Stratpharma AG Pharmaceuticals: MajorHealth Technology Stratpharma AG specializes in the development and licensing of novel medical devices and pharmaceutical products. Its products are used for scar management, abnormal scar prevention and invasive therapies. The company was founded in 2005 and is headquartered in Basel, Switzerland.^ | Health Technology |
TOPADUR Pharma AG
![]() TOPADUR Pharma AG Pharmaceuticals: MajorHealth Technology TOPADUR Pharma AG is a Swiss-based biotech company located in Schlieren. TOPADUR is a patient-oriented biotech company that aims to enhance the quality of life through cutting-edge research. The private company is developing a new class of compounds based on their innovative cgmp-enzyme regulation system, which corrects locally cgmp levels. These compounds target high medical needs and can be used to treat several ageing-related diseases resulting from insufficient local blood-circulation. The company was founded in 2015 by Reto Naef, who has been the CEO since then. | Health Technology |
Bottmedical AG
![]() Bottmedical AG Medical SpecialtiesHealth Technology Bottmedical AG is a Swiss company that produces CINNA & Naturaligner, which are the world's first antibacterial braces. The private company is based in Basel, Switzerland. These braces correct, protect, and retain teeth while continuously supporting oral hygiene. The company was founded in 2019 by Pascal Brenneisen, Tino Töpper, Jeannette von Jackowski, Bert Müller, Bekim Osmani, Guido Sigron, Tobias Hollritt. Tino Töpper has been the CEO since 2019. | Health Technology |
Bottneuro AG
![]() Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | Technology Services |
- Stock Market
- Insiders
- Pascal Brenneisen